Immunoglobulins, Intravenous
"Immunoglobulins, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
| Descriptor ID |
D016756
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393.536 D12.776.124.486.485.114.632 D12.776.124.790.651.114.632 D12.776.377.715.548.114.632
|
| Concept/Terms |
Immunoglobulins, Intravenous- Immunoglobulins, Intravenous
- Intravenous IG
- Intravenous Antibodies
- IVIG
- Immune Globulin, Intravenous
- Intravenous Immune Globulin
- Antibodies, Intravenous
- Intravenous Immunoglobulins
- IV Immunoglobulins
- Immunoglobulins, IV
Intravenous Immunoglobulins, Human- Intravenous Immunoglobulins, Human
- Human Intravenous Immunoglobulins
- Immunoglobulins, Human Intravenous
- Immune Globulin Intravenous (Human)
- Immunoglobulins, Intravenous, Human
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulins, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins, Intravenous".
This graph shows the total number of publications written about "Immunoglobulins, Intravenous" by people in this website by year, and whether "Immunoglobulins, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 5 | 2 | 7 |
| 2017 | 27 | 25 | 52 |
| 2018 | 32 | 24 | 56 |
| 2019 | 14 | 8 | 22 |
| 2020 | 19 | 39 | 58 |
| 2021 | 19 | 25 | 44 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.
-
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children. Pediatr Infect Dis J. 2021 12 01; 40(12):e491-e492.
-
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 12 01; 6(12):1451-1460.
-
Presence of Severe Acute Respiratory Syndrome Coronavirus 2 in the Cerebrospinal Fluid of Guillain-Barré Syndrome Patients Requires Validation. Pediatr Infect Dis J. 2021 12 01; 40(12):e527.
-
COVID-19-associated Acute Disseminated Encephalomyelitis-like Disease in 2 Children. Pediatr Infect Dis J. 2021 11 01; 40(11):e445-e450.
-
Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage. Pediatr Infect Dis J. 2021 11 01; 40(11):e390-e394.
-
Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. J Clin Invest. 2021 10 15; 131(20).
-
Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia. Crit Care Med. 2021 09 01; 49(9):e870-e873.
-
Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106072.
-
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6).
-
A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK. Br J Haematol. 2022 01; 196(2):351-355.